ANN ARBOR ? MichBio, the state’s life sciences trade association, will be hosting a workshop on April 22 to look at how biotechnology companies can select the best funding sources. The workshop is scheduled in the afternoon just before the MichBio annual meeting.
The workshop is called Capital Formation: Lost in Translation. Industry experts will demystify the benefits, processes and lingo involved in raising money from non-dilutive funding like SBIR and STTR programs, debt sources such as the Michigan Economic Development Corp., and equity sources such as venture capital and corporate investment. How to select the best funding source and create a compelling message will also be discussed. Break-out sessions will evaluate a case study in each area. This will be a valuable gathering for those involved or interested in starting or growing life sciences businesses.
Speakers include Roger Newton, former president, Esperion Therapeutics, senior VP, Pfizer; Jeff LaBine, principal, Miller Canfield; Ian Bund, chairman, Plymouth Venture Partners; Timothy Mayleben, president, and COO, Nighthawk Radiology Holdings; Andy Jakimcius, Principal Consultant, Biotechnology Business Consultants; Wayne Harvey, Senior Business Development Specialist, U of M Office of Technology Transfer; Scott Merz, President, MC3, Inc.; Skip Simms, Executive Director, Pre-Seed Fund, Ann Arbor SPARK; Mike Psarouthakis, Portfolio Manager, Michigan Economic Development Organization; and Duane Day, President, Molecular Innovations.
The workshop runs from 2-5:30 pm at the Kensington Court Hotel in Ann Arbor.
Prices:
Workshop Only: Members- $75 Non-members- $100
Workshop + Annual Meeting: Members- $130 Non-members- $185
Annual Meeting Only: Members- $80 Non-members- $110
Annual Meeting Only, After 4/20: Members- $100 Non-members- $130
For more information, click on MichBio.Org
a>>
